EmPLiCS: An empirical approach for structure-based design of natural peptide drugs

被引:4
|
作者
Ishida, H [1 ]
Shirai, T [1 ]
Matsuda, Y [1 ]
Kato, Y [1 ]
Ohno, M [1 ]
Isaji, T [1 ]
Yamane, T [1 ]
机构
[1] Nagoya Univ, Grad Sch Engn, Dept Biotechnol & Biomat Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan
来源
JOURNAL OF BIOCHEMISTRY | 2000年 / 128卷 / 04期
关键词
computer program; peptide drug; protein evolution; rational drug design;
D O I
10.1093/oxfordjournals.jbchem.a022788
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The computer implementation of a peptide drug-design strategy has been developed. The system is named EmPLiCS (Empirical Peptide Ligand Construction System) according to the strategy of the system, which searches for peptide-ligand structures by referring to empirical rules that are derived from known protein 3D structures. The system was tested on several known peptide-protein complexes. The results demonstrated the ability of this system to detect key residues of peptides that are crucial for interaction with their specific proteins. The system also showed the ability to detect the main chain trace of these peptides, Some of the main chain atoms were detected even though the complete primary structures were not reproduced, suggesting that main chain structure is important in peptide-protein recognition. The results of the present study demonstrated that the empirical rules-based system can generate significant information for use in the design of natural peptide drugs.
引用
收藏
页码:561 / 574
页数:14
相关论文
共 50 条
  • [1] An evolutionary approach for structure-based design of natural and nonnatural peptidic ligands
    Budin, N
    Ahmed, S
    Majeux, N
    Caflisch, A
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2001, 4 (08) : 661 - 673
  • [2] NMR structure-based design of α-MSH peptide analogues
    Jinfa, Y
    Kövér, KE
    Gu, X
    Han, G
    Vagner, J
    Xiong, C
    Zhang, J
    Trivedi, DB
    Kavarana, M
    Hruby, VJ
    BIOPOLYMERS, 2003, 71 (03) : 328 - 328
  • [3] Structure-based design of a macrocyclic inhibitor for peptide deformylase
    Hu, XB
    Nguyen, KT
    Verlinde, CLMJ
    Hol, WGJ
    Pei, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) : 3771 - 3774
  • [4] Structure-based design of AIDS drugs and the development of resistance
    Wlodawer, A
    VOX SANGUINIS, 2002, 83 : 23 - 26
  • [5] Structure-based design of an agonistic peptide targeting Fas
    Yoshimori, A
    Takasawa, R
    Hayakawa, A
    Mizuno, M
    Yoshida, J
    Tanuma, S
    APOPTOSIS, 2005, 10 (02) : 323 - 329
  • [6] FLEXIBLE PEPTIDE EPITOPES AS TEMPLATES FOR STRUCTURE-BASED DESIGN
    MCDOWELL, RS
    FASEB JOURNAL, 1995, 9 (06): : A1253 - A1253
  • [7] Structure-based design of an agonistic peptide targeting Fas
    A. Yoshimori
    R. Takasawa
    A. Hayakawa
    M. Mizuno
    J. Yoshida
    S. Tanuma
    Apoptosis, 2005, 10 : 323 - 329
  • [8] NMR structure-based design of α-MSH peptide analogues
    Ying, Jinfa
    Kover, Katalin E.
    Gu, Xuyuan
    Han, Guoxia
    Vagner, Josef
    Cai, Minying
    Cabello, Christopher M.
    Xiong, Chiyi
    Zhang, Junyi
    Trivedi, Dev B.
    Kavarana, Malcolm J.
    Hruby, Victor J.
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 567 - 568
  • [9] Structure-based design of nucleic acid binding drugs
    Chen, Q
    Kuntz, ID
    Shafer, RH
    STRUCTURE, MOTION, INTERACTION AND EXPRESSION OF BIOLOGICAL MACROMOLECULES, VOL 1, 1998, : 227 - 231
  • [10] Structure-based design of anti-trypanosomal drugs
    Pinheiro, Matheus Pinto
    da Rocha, Josmar Rodrigues
    Cheleski, Juliana
    Wiggers, Helton Jose
    Montanari, Carlos Alberto
    Nonato, Maria Cristina
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C294 - C294